Thinking of joining a study?

Register your interest

NCT05872009 | Not yet recruiting | Gestational Diabetes


Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"
Sponsor:

Oslo University Hospital

Information provided by (Responsible Party):

Meryam Sugulle

Brief Summary:

The GaP study is designed to close important knowledge gaps by: exploring placental health and cellular ageing in GDM and the association with neonatal outcome evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM

Condition or disease

Gestational Diabetes

Cardiovascular Diseases

Placenta Diseases

Detailed Description:

The incidence of gestational diabetes mellitus (GDM) is increasing. GDM has potential adverse short and long term health effects for both the women and her offspring, and involves dysfunctional interaction between placenta and the maternal body. The burden for the individual, the health system and society warrants further investigations into the placental-maternal crosstalk in GDM in order to improve personalized pregnancy surveillance and follow-up. In Oslo county, nearly twice as many women who give birth suffer from GDM (5.7%) than from preeclampsia (2.3%). The large obstetric department at Ullevål provides an optimal environment for novel translational studies and clinical practical aspects of GDM. The GaP study is designed to close important knowledge gaps by: exploring placental health and cellular ageing in GDM and the association with neonatal outcome evaluating the effectiveness of current and novel maternal health follow-up strategies after GDM}}

Study Type : Observational
Estimated Enrollment : 350 participants
Official Title : The GaP Study: Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health
Actual Study Start Date : June 1, 2023
Estimated Primary Completion Date : June 2026
Estimated Study Completion Date : June 2026

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: Female
Criteria
Inclusion Criteria
  • Pregnant women >18 years with GDM giving birth at Oslo University hospital Ullevål.
  • Control group of gestational age matched euglycemic, normotensive pregnancies
Exclusion Criteria
  • reduced fetal movements,
  • epilepsy
  • thyroidea dysfunction
  • hypertensive disorder of pregnancy
  • non-communicable disease
  • Communicable disease (such as HIV)
  • type 1 or type 2 diabetes.
  • not able to understand Norwegian or English.
  • under legal guardianship.

Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"

Location Details


Please Choose a site



Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Norway,

Oslo University Hospital

Oslo, Norway, 0407

Loading...